Illumina, Inc. is a leading global biotechnology company based in San Diego, California, specializing in genomic analysis technologies since its founding in 1998. Renowned for its innovative sequencing, genotyping, and gene expression solutions, Illumina serves a variety of markets, including research, clinical diagnostics, and agricultural genomics, thereby significantly contributing to the advancement of personalized medicine. The company is committed to transforming human health through ongoing innovation and has established a prominent position in the genomics landscape by enabling breakthroughs in genetic research and diagnostics.